* Chemed Corp reported quarterly adjusted earnings of $5.64 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $5.32. The mean expectation of three analysts for the quarter was for earnings of $5.76 per share. Wall Street expected results to range from $5.65 to $5.87 per share.
* Revenue rose 7.4% to $606.18 million from a year ago; analysts expected $612.22 million.
* Chemed Corp's reported EPS for the quarter was $5.00.
* The company reported quarterly net income of $75.78 million.
* Chemed Corp shares had risen by 1.3% this quarter and gained 4.1% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the healthcare facilities & services peer group is also "strong buy"
Wall Street's median 12-month price target for Chemed Corp is 697.00 This summary was machine generated from LSEG data October 30 at 02:58 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 5.76 5.64 Missed
Jun. 30 2024 5.59 5.47 Missed
Mar. 31 2024 5.48 5.20 Missed
Dec. 31 2023 6.25 6.60 Beat
Comments